CO15 DIAGNOSTIC USEFULNESS OF SINGLE BALLOON ENTEROSCOPY IN CHILDREN WITH GASTROINTESTINAL DISORDERS UNDEFINED AT CONVENTIONAL ENDOSCOPY

IFX for remission 7 were still in remission, 5 restarted biologic therapy (3 Adalimumab, 2 IFX), 1 underwent ileal resection. No serious adverse events or malignancies were reported. Conclusions: In our cohort of IBD pts, IFX maintenance therapy was a durable and effective treatment over a 3-year period in children with CD, it appeared also an effective therapeutic option to avoid or postpone colectomy in UC pts.